𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Vindesine/Cisplatin chemotherapy in relapsed or primarily resistant small-cell carcinoma of the lung

✍ Scribed by Niederle, N. ;Schütte, J. ;Krischke, W. ;Seeber, S. ;Schmidt, C. G.

Book ID
105288687
Publisher
Springer-Verlag
Year
1984
Tongue
English
Weight
526 KB
Volume
62
Category
Article
ISSN
1432-1440

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Therapeutic efficacy and pharmacokinetic
Therapeutic efficacy and pharmacokinetics of vindesine and vindesine-cisplatin in previously treated patients with non-small cell lung carcinoma
✍ Joachim Z. Fuks; Merrill J. Egorin; Joseph Aisner; David A. Echo; Stanley Ostrow 📂 Article 📅 1983 🏛 Springer 🌐 English ⚖ 480 KB

Twenty-nine patients with non-small cell lung cancer refractory to prior therapy were treated with either vindesine (VDS) alone (3 mg/m2 every week) or the combination of VDS plus cisplatin (DDP) (100 mg/m2 every 28 days). Serial blood and urine samples were collected to assess the pharmacokinetics

Phase-II study of vindesine and hexameth
Phase-II study of vindesine and hexamethylmelamine in patients with relapsing small cell carcinoma of the lung
✍ Rudolf A. Joss; Jean-Paul Obrecht; Walter F. Jungi; Pierre Alberto; Christian Sa 📂 Article 📅 1984 🏛 Springer 🌐 English ⚖ 163 KB

Twenty-five patients with measurable small cell lung cancer relapsing after first-line chemotherapy were treated with vindesine 3 mg/m2 IV on days 1 and 8 and hexamethylmelamine 100 mg/m2 PO on days 1-14, repeated every 3 weeks. Among 18 fully evaluable patients there was 1 partial remission lasting